FDA approvals top most read Healio Dermatology articles of week

FDA approvals of treatments for rosacea lesions and acne scars were the most read articles during the past week in Healio Dermatology.

Studies focusing on pediatric atopic dermatitis and pruritis also were among the top read stories:

1. FDA approves Galderma's Soolantra Cream for treatment of rosacea lesions

Galderma Laboratories announced that the FDA approved Soolantra Cream for once-daily, topical treatment of inflammatory rosacea lesions, according to a press release.

Linda Stein Gold

“Rosacea is a common and challenging condition to manage as it tends to vary from patient to patient, often requiring a tailored approach … we are always looking for innovative new treatments,” Linda Stein Gold, MD, a Galderma consultant and clinical investigator for the phase 3 studies of Soolantra Cream (ivermectin cream, 1%), said in the release. Read more

2. FDA approves Suneva's Bellafill dermal filler for treatment of acne scars

Suneva Medical announced that the FDA has approved its dermal filler, Bellafill, for treating acne scars.

Ava Shamban

Bellafill is designed to add volume to the skin to smooth out pitted acne scars through an in-office injection procedure with little-to-no downtime, according to a company press release. “I look forward to using this proven treatment option with patients,” investigator Ava Shamban, MD, said in the release. Read more

3. Lion Biotechnologies files IND application for metastatic melanoma study

Lion Biotechnologies announced the filing of an investigational new drug application with the U.S. Food and Drug Administration to conduct a phase 2 clinical trial of LN-144 for the treatment of patients with refractory metastatic melanoma.

LN-144, the company’s lead product candidate, is a ready-to-infuse autologous T-cell therapy utilizing tumor-infiltrating lymphocytes derived from the patient’s own tumor. Read more

4. Pediatric atopic dermatitis potentially associated with central obesity, increased BP

Moderate-to-severe atopic dermatitis was found to have a potential association with central obesity and increased blood pressure in children and adolescents.

Jonathan I. Silverberg

Jonathan I. Silverberg, MD, PhD, MPH, and colleagues studied 132 patients with active moderate-to-severe atopic dermatitis and 143 controls recruited from seven U.S. dermatology referral centers between April 1, 2009, and Dec. 31, 2012. Read more

5. Pruritus prevalent in patients with small-fiber neuropathies

Pruritus appears to be a common and frequently overlooked symptom of small-fiber neuropathies, according to a study.

The most common sensory symptoms reported by the 41patients with SFN who responded to a questionnaire were burning (77.5%), pain (72.5%), heat (70.2%) and numbness (67.5%). Pruritus was reported as a symptom in 68.3% of patients with SFN. Read more